- Home
- ALBT vs NDRA Comparison
ALBT vs NDRA Comparison
Compare ALBT & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- NDRA
- Stock Information
- Founded
- ALBT 2014
- NDRA 2007
- Country
- ALBT United States
- NDRA United States
- Employees
- ALBT N/A
- NDRA N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ALBT Health Care
- NDRA Health Care
- Exchange
- ALBT Nasdaq
- NDRA Nasdaq
- Market Cap
- ALBT 3.1M
- NDRA 3.6M
- IPO Year
- ALBT N/A
- NDRA 2017
- Fundamental
- Price
- ALBT $3.66
- NDRA $6.01
- Analyst Decision
- ALBT
- NDRA Strong Buy
- Analyst Count
- ALBT 0
- NDRA 1
- Target Price
- ALBT N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- ALBT 90.7K
- NDRA 36.2K
- Earning Date
- ALBT 11-12-2024
- NDRA 11-15-2024
- Dividend Yield
- ALBT N/A
- NDRA N/A
- EPS Growth
- ALBT N/A
- NDRA N/A
- EPS
- ALBT N/A
- NDRA N/A
- Revenue
- ALBT N/A
- NDRA N/A
- Revenue This Year
- ALBT N/A
- NDRA N/A
- Revenue Next Year
- ALBT N/A
- NDRA N/A
- P/E Ratio
- ALBT N/A
- NDRA N/A
- Revenue Growth
- ALBT N/A
- NDRA N/A
- 52 Week Low
- ALBT $2.11
- NDRA $4.01
- 52 Week High
- ALBT $21.60
- NDRA $2,240.00
- Technical
- Relative Strength Index (RSI)
- ALBT 51.99
- NDRA 51.58
- Support Level
- ALBT $3.20
- NDRA $5.60
- Resistance Level
- ALBT $3.81
- NDRA $6.29
- Average True Range (ATR)
- ALBT 0.41
- NDRA 0.60
- MACD
- ALBT -0.01
- NDRA 0.02
- Stochastic Oscillator
- ALBT 50.30
- NDRA 27.29
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.